We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ingersoll Rand Inc. (IR - Free Report) yesterday announced that it bought Montelimar, France-based Albin Pump SAS. The transaction value (which was kept under wraps) was financed with available cash.
Shares of Ingersoll gained 3.3% yesterday, ending the trading session at $36.21.
Albin Pump specializes in manufacturing electric peristaltic pumps. These pumps are used mainly in mining, chemical processing, food and beverage, industrial water and municipal water markets.
Discussion on Buyout
Notably, the addition of Albin Pump to Ingersoll’s portfolio will strengthen the company’s efforts to expand its offerings in the fluid management arena and enhance its technical capabilities too. Further, Albin Pump’s solid customer base and its presence in multiple end markets will prove to be a boon for Ingersoll.
Notably, the acquired positive displacement pumps (electrically driven) will strongly complement Ingersoll’s existing product brands including Milton Roy, ARO and others. Albin Pump will be integrated with Ingersoll’s Precision & Science Technologies segment.
The Precision & Science Technologies segment is engaged in making liquid and gas pumps for use in life sciences, lab and medical markets as well as doing and metering pumps for use in multiple industries. It generated revenues of $195.8 million in second-quarter 2020, representing 15.5% of Ingersoll’s total revenues generated in the period.
Zacks Rank, Price Performance and Estimate Trend
With a market capitalization of $14.6 billion, Ingersoll currently carries a Zacks Rank #5 (Strong Sell). The company is suffering a setback from the prevalent pandemic crisis and expects a slow recovery in the markets during the third quarter of 2020. High leverage and forex woes are its other concerns.
In the past three months, the stock has rallied 17.6% compared with the industry’s growth of 10.6%.
Also, the Zacks Consensus Estimate for its 2020 earnings per share is pegged at $1.26 and the same for 2021 stands at $1.64, implying an increase of 20% and 11.6% each from the respective figures in the past 60 days. Further, the consensus estimate for third-quarter earnings is pegged at 30 cents, suggesting growth from 26 cents, which was 60 days ago.
Three better-ranked stocks in the industry are Tennant Company (TNC - Free Report) , Altra Industrial Motion Corp. and Graco Inc. (GGG - Free Report) . While Tennant currently sports a Zacks Rank #1 (Strong Buy), both Altra Industrial and Graco carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, earnings estimates for these companies have improved for the current year. Further, earnings surprise for the last reported quarter was 380.00% for Tennant, 76.47% for Altra Industrial and 37.04% for Graco.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Ingersoll (IR) Acquires Albin Pump, Boosts Fluid Technologies
Ingersoll Rand Inc. (IR - Free Report) yesterday announced that it bought Montelimar, France-based Albin Pump SAS. The transaction value (which was kept under wraps) was financed with available cash.
Shares of Ingersoll gained 3.3% yesterday, ending the trading session at $36.21.
Albin Pump specializes in manufacturing electric peristaltic pumps. These pumps are used mainly in mining, chemical processing, food and beverage, industrial water and municipal water markets.
Discussion on Buyout
Notably, the addition of Albin Pump to Ingersoll’s portfolio will strengthen the company’s efforts to expand its offerings in the fluid management arena and enhance its technical capabilities too. Further, Albin Pump’s solid customer base and its presence in multiple end markets will prove to be a boon for Ingersoll.
Notably, the acquired positive displacement pumps (electrically driven) will strongly complement Ingersoll’s existing product brands including Milton Roy, ARO and others. Albin Pump will be integrated with Ingersoll’s Precision & Science Technologies segment.
The Precision & Science Technologies segment is engaged in making liquid and gas pumps for use in life sciences, lab and medical markets as well as doing and metering pumps for use in multiple industries. It generated revenues of $195.8 million in second-quarter 2020, representing 15.5% of Ingersoll’s total revenues generated in the period.
Zacks Rank, Price Performance and Estimate Trend
With a market capitalization of $14.6 billion, Ingersoll currently carries a Zacks Rank #5 (Strong Sell). The company is suffering a setback from the prevalent pandemic crisis and expects a slow recovery in the markets during the third quarter of 2020. High leverage and forex woes are its other concerns.
.jpg)
In the past three months, the stock has rallied 17.6% compared with the industry’s growth of 10.6%.
Also, the Zacks Consensus Estimate for its 2020 earnings per share is pegged at $1.26 and the same for 2021 stands at $1.64, implying an increase of 20% and 11.6% each from the respective figures in the past 60 days. Further, the consensus estimate for third-quarter earnings is pegged at 30 cents, suggesting growth from 26 cents, which was 60 days ago.
Ingersoll Rand Inc. Price and Consensus
Ingersoll Rand Inc. price-consensus-chart | Ingersoll Rand Inc. Quote
Stocks to Consider
Three better-ranked stocks in the industry are Tennant Company (TNC - Free Report) , Altra Industrial Motion Corp. and Graco Inc. (GGG - Free Report) . While Tennant currently sports a Zacks Rank #1 (Strong Buy), both Altra Industrial and Graco carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, earnings estimates for these companies have improved for the current year. Further, earnings surprise for the last reported quarter was 380.00% for Tennant, 76.47% for Altra Industrial and 37.04% for Graco.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>